Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis

J Bras Pneumol. 2018 Sep-Oct;44(5):439-441. doi: 10.1590/S1806-37562017000000325.

[Article in English, Portuguese]

Authors

Fernanda Sales da Cunha¹, Solange Oliveira Rodrigues Valle¹, José Elabras Filho¹, Sérgio Duarte Dortas Júnior^{1

2}, Alfeu Tavares França¹

Affiliations

¹ . Serviço de Imunologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.
² . Coordenação Acadêmica do Internato, Universidade Iguaçu, Nova Iguaçu (RJ) Brasil.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Allergic Agents / administration & dosage*
Antibodies, Monoclonal, Humanized / administration & dosage*
Aspergillosis, Allergic Bronchopulmonary / drug therapy*
Asthma / drug therapy*
Chemotherapy, Adjuvant
Drug Therapy, Combination
Female
Humans
Middle Aged
Omalizumab / administration & dosage*
Treatment Outcome

Substances

Anti-Allergic Agents
Antibodies, Monoclonal, Humanized
Omalizumab